HLS Therapeutics Inc
F:74D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HLS Therapeutics Inc
F:74D
|
CA |
|
C
|
CBRE Group Inc
XBER:RF6
|
US |
|
B
|
Bper Banca SpA
F:4BE
|
IT |
|
Nikon Corp
F:NKN
|
JP |
|
L
|
Lam Research Corp
XMUN:LAR
|
US |
|
B
|
Bank of Montreal
XBER:BZZ
|
CA |
|
K
|
Kinross Gold Corp
DUS:KIN2
|
CA |
Wall St Price Targets
74D Price Targets Summary
HLS Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 74D is 5.78 EUR with a low forecast of 3.26 EUR and a high forecast of 9.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 74D's stock price target?
Price Target
5.78
EUR
According to Wall Street analysts, the average 1-year price target for 74D is 5.78 EUR with a low forecast of 3.26 EUR and a high forecast of 9.13 EUR.
What is the Revenue forecast for HLS Therapeutics Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for HLS Therapeutics Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 10%.
